Par Pharmaceutical Cos News

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Strukturierte Produkte

Aktion

Portfolio

Watchlist

13.03.24	Endo Intl's Par Pharma Recalls Treprostinil Injection For Silicone Particulates (RTTNews)
14.05.18	Indivior Settles Patent Infringement Litigation On SUBOXONE Sublingual Film (RTTNews)
13.04.17	BioMarin Enters Into Settlement Agreement With Par Pharma Related To Kuvan (RTTNews)
18.05.15	Nächster Pharma-Milliarden-Deal: Endo will Generikahersteller PAR schlucken (dpa-afx)
18.05.15	Endo International To Acquire Par Pharma; Deal Valued At $8.05 Bln - Quick Facts (RTTNews)
10.10.14	R-Tech Ueno Announces Settlement Deal That Resolves Patent Litigation In U.S. (RTTNews)
17.09.12	Sky Growth Acquisition Corporation -- Moody's: Par upsized term loan credit negative; no rating impact (Moodys)
06.09.12	Sky Growth Acquisition Corporation -- Moody's assigns B2 CFR to Par Pharmaceuticals; stable outlook (Moodys)
16.07.12	Par Pharmaceutical: Übernahmeofferte sorgt für Kurssprung (Aktiencheck)
07.05.08	Par Pharmaceutical Acquires Spectrum Pharmaceutical's Interest In Sumatriptan Injection (PR Newswire)
20.12.07	Par Pharmaceutical Reports Third-Quarter 2007 Results (PR Newswire)
27.09.07	Chinese SFDA Grants Immtech Fast Track Status (PR Newswire)
06.09.07	Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts' Meeting September 28, 2007 (PR Newswire)
05.04.07	Par Pharmaceutical to Present at CIBC World Markets Annual Biotechnology & Specialty Pharmaceuticals Conference (PR Newswire)
29.01.07	Par Pharmaceutical Receives Approval of Generic Inderal-LA(R) (PR Newswire)
14.12.06	Par Pharmaceutical Provides Update on Financial Restatement (PR Newswire)
03.11.06	NovaDel Pharma Receives FDA Approval of NitroMist(TM) (Businesswire)
28.02.06	Par Pharmaceutical Reports Sales and Earnings for 2005 (PR Newswire)
24.02.06	Par Pharmaceutical Halts Shipment of Generic Flonase(R) (PR Newswire)
24.10.05	Par Announces Strategic Alliance With MN Pharmaceuticals (PR Newswire)
06.07.05	Par Pharmaceutical Announces FDA Approval of Megace(R) ES for Anorexia, Cachexia, or an Unexplained, Significant Weight Loss in Patients With a Diagnosis of AIDS (PR Newswire)

Newssuche

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Lonza Grp	590.60	1.48 %	K V
Novartis	95.67	0.09 %	K V
Swiss Re	139.20	-0.14 %	K V
Nestle	77.28	-0.26 %	K V
Zurich Insur Gr	552.20	-0.29 %	K V
Sonova Hldg	312.50	-2.10 %	K V
UBS Group	31.51	-2.57 %	K V
Sika	227.20	-2.61 %	K V
Logitech Intl	88.64	-3.10 %	K V
Kuehne+Nagel Int	200.40	-3.47 %	K V